Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Hess

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Future Oncology (London, England)|February 23, 2019
Sequential therapy with ramucirumab and/or checkpoint inhibitors for non-small-cell lung cancer in routine practiceCliff Molife, Lisa M Hess, Zhanglin Lin Cui, et al.
Journal of Gastrointestinal Cancer|December 16, 2016
Patient Experience After Receiving a Diagnosis of Gastric Cancer in the USALisa M Hess, Zhanglin Lin Cui, Yixun Wu, et al.
Hematology (Amsterdam, Netherlands)|January 1, 2015
Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USADaniel S Mytelka, Li Li, Dana Stafkey-Mailey, et al.
Personalized Medicine|February 7, 2023
Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USANaleen Raj Bhandari, Lisa M Hess, Rohan C Parikh, et al.
Gynecologic Oncology|November 6, 2012
Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group studyLisa M Hess, William E Brady, Laura J Havrilesky, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2022
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database StudyAnthony R Mato, Lisa M Hess, Yongmei Chen, et al.
Journal of Thoracic Disease|February 13, 2019
First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysisLisa M Hess, Amy M DeLozier, Fanni Natanegara, et al.
The American Journal of Managed Care|April 20, 2021
Treatment patterns for patients with advanced/metastatic cancers by site of careSuvapun Bunniran, Yihua Xu, Cliff Molife, et al.
Journal of Patient-Reported Outcomes|June 22, 2026
Psychometric analysis of new lymphoma-specific patient-reported symptom measures derived from the EORTC item libraryAngély Loubert, Kristin Creel, Naleen Raj Bhandari, et al.
The Journal of Molecular Diagnostics : JMD|June 10, 2022
Diagnostic Value and Cost-Effectiveness of Next-Generation Sequencing-Based Testing for Treatment of Patients with Advanced/Metastatic Non-Squamous Non-Small-Cell Lung Cancer in the United StatesDenise Zou, Weicheng Ye, Lisa M Hess, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Future Oncology (London, England)|February 23, 2019
Sequential therapy with ramucirumab and/or checkpoint inhibitors for non-small-cell lung cancer in routine practiceCliff Molife, Lisa M Hess, Zhanglin Lin Cui, et al.
Journal of Gastrointestinal Cancer|December 16, 2016
Patient Experience After Receiving a Diagnosis of Gastric Cancer in the USALisa M Hess, Zhanglin Lin Cui, Yixun Wu, et al.
Hematology (Amsterdam, Netherlands)|January 1, 2015
Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USADaniel S Mytelka, Li Li, Dana Stafkey-Mailey, et al.
Personalized Medicine|February 7, 2023
Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USANaleen Raj Bhandari, Lisa M Hess, Rohan C Parikh, et al.
Gynecologic Oncology|November 6, 2012
Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group studyLisa M Hess, William E Brady, Laura J Havrilesky, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2022
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database StudyAnthony R Mato, Lisa M Hess, Yongmei Chen, et al.
Journal of Thoracic Disease|February 13, 2019
First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysisLisa M Hess, Amy M DeLozier, Fanni Natanegara, et al.
The American Journal of Managed Care|April 20, 2021
Treatment patterns for patients with advanced/metastatic cancers by site of careSuvapun Bunniran, Yihua Xu, Cliff Molife, et al.
Journal of Patient-Reported Outcomes|June 22, 2026
Psychometric analysis of new lymphoma-specific patient-reported symptom measures derived from the EORTC item libraryAngély Loubert, Kristin Creel, Naleen Raj Bhandari, et al.
The Journal of Molecular Diagnostics : JMD|June 10, 2022
Diagnostic Value and Cost-Effectiveness of Next-Generation Sequencing-Based Testing for Treatment of Patients with Advanced/Metastatic Non-Squamous Non-Small-Cell Lung Cancer in the United StatesDenise Zou, Weicheng Ye, Lisa M Hess, et al.
Pageof 11